Skip to main content

LVH Diagnostic Criteria on ECG

Ecg criteria for lvh

Left Ventricular Hypertrophy (LVH) on ECG: Diagnostic Criteria Explained

Left ventricular hypertrophy refers to an increase in left ventricular muscle mass, most commonly due to chronic pressure overload such as long-standing hypertension or aortic stenosis. Although echocardiography is the gold standard for diagnosis, the ECG remains a widely used, inexpensive, and readily available screening tool. Several ECG criteria have been developed to identify LVH, each with its own strengths and limitations.


Why ECG Criteria Matter

ECG criteria for LVH are highly specific but relatively insensitive. This means that when criteria are met, LVH is likely present, but a normal ECG does not exclude LVH. ECG-detected LVH is clinically important because it independently predicts cardiovascular morbidity and mortality, including heart failure, arrhythmias, stroke, and sudden cardiac death.


Sokolow–Lyon Criteria

The Sokolow–Lyon criteria are among the oldest and most commonly taught ECG criteria for LVH. They rely on increased QRS voltage in precordial and limb leads, reflecting increased myocardial mass.


Diagnostic thresholds include:


R wave in aVL greater than 11 mm


R wave in V5 or V6 greater than 26 mm


Sum of S wave in V1 and R wave in V5 (or V6) greater than 35 mm



These criteria are easy to apply and widely used in clinical practice. However, they are less sensitive in obese patients, older adults, and those with chronic lung disease, and may overestimate LVH in young, thin individuals.


Cornell Voltage Criteria

The Cornell criteria improve diagnostic performance by incorporating both limb and precordial leads and by using sex-specific cutoffs.


The formula is:


R wave in aVL + S wave in V3



Diagnostic cutoffs:


Greater than 28 mm in men


Greater than 20 mm in women



Cornell criteria have better sensitivity than Sokolow–Lyon and correlate more closely with left ventricular mass on echocardiography. They are particularly useful in hypertensive patients and are commonly used in research studies and clinical trials.


Kaito and Spodick Criterion

The Kaito and Spodick criterion is a simpler qualitative rule based on R-wave progression in the lateral precordial leads.


Criterion:


R wave amplitude in V6 greater than R wave amplitude in V5



This finding reflects altered ventricular depolarization due to increased left ventricular mass. While not widely used alone, it can serve as a supportive finding when other voltage criteria are borderline or inconclusive.


Associated ECG Findings in LVH

Voltage criteria may be accompanied by additional ECG features that increase diagnostic confidence:


Left axis deviation


QRS widening


Left atrial enlargement (biphasic P wave in V1)


ST depression and T-wave inversion in lateral leads (LVH strain pattern)



The presence of a strain pattern is particularly significant, as it is associated with more advanced disease and worse prognosis.


Limitations of ECG Diagnosis

Despite multiple criteria, ECG has limited sensitivity for LVH. Factors that reduce ECG voltage include obesity, pericardial effusion, chronic obstructive pulmonary disease, and infiltrative cardiomyopathies. Conversely, high voltage may be seen in athletes and young individuals without true hypertrophy.


Clinical Implications

Detection of LVH on ECG should prompt further evaluation, usually with echocardiography, to confirm diagnosis and assess severity and etiology. Regression of ECG-LVH with antihypertensive therapy is associated with improved cardiovascular outcomes, making ECG a useful tool for long-term risk stratification and follow-up.


Conclusion

ECG criteria for left ventricular hypertrophy, including Sokolow–Lyon, Cornell, and Kaito–Spodick criteria, provide valuable diagnostic and prognostic information. While not definitive on their own, they remain an essential part of cardiovascular assessment and should always be interpreted in clinical context alongside imaging and patient risk factors.


Comments

Popular posts from this blog

STEMI ECG Criteria and Universal Definition of MI

  STEMI ECG Criteria and the Universal Definition of Myocardial Infarction: A Complete Guide for Clinicians Early and accurate diagnosis of acute myocardial infarction (AMI) remains the cornerstone of reducing morbidity and mortality in patients presenting with chest pain. Among all forms of acute coronary syndromes (ACS), ST-elevation myocardial infarction (STEMI) represents the most time-sensitive emergency, requiring immediate reperfusion therapy. This article provides a clinically relevant summary of the STEMI ECG criteria and the Universal Definition of Myocardial Infarction (UDMI), based on the latest consensus guidelines from the ESC, ACC, AHA, and WHF. --- 1. Understanding STEMI: Why Accurate ECG Interpretation Matters A 12-lead ECG remains the first and most critical diagnostic test when evaluating suspected myocardial infarction. STEMI is identified when there is evidence of acute coronary artery occlusion, producing transmural ischemia and characteristic ST-segment eleva...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...